An observational study in Chronic Otitis Media, sponsored by Cochlear. Completed at 6 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-07.
Sponsored by Cochlear · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The objective of this multicentre study is to evaluate the standard of care of participants diagnosed with Chronic Otitis Media that have already gone through a first middle ear surgery but still have at least a moderate hearing loss. The study has a retrospective part (extraction of medical chart data) and a prospective part with a survey and three questionnaires collecting data on the use of health care services, on health related quality of life and hearing performance.
241 studies on the registry are indexed under Otitis Media; 32 are open to participants now.
This study's enrollment of 69 is below the median of 150 across 57 observational studies indexed under Otitis Media.
Browse Otitis Media studies →Cochlear is the lead sponsor of 92 studies on the registry; 9 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 15 (88%) have results posted.
Counted across the registry records on this site, refreshed daily.
Adult participants with a history of chronic otitis media who have undergone a primary tympanoplasty to improve hearing between 2010-2016 but still have conductive or mixed hearing loss.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
For France only:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Questionnaires: Health Utilities Index Mark III, Chronic Otitis Media Outcome Test-15 and Speech, Spatial, and Qualities of Hearing Scale-12 Survey: Client Service Receipt Inventory (adapted version)
Number and Type of Contacts With Health Care Providers
Contacts are obtained from medical records, counted and categorized.
Time frame: From primary tympanoplasty to time of enrolment, up to 13 years
Number and Type of Interventions and/or Procedures
Medical examinations, surgical procedures and hearing rehabilitation are obtained from medical records, counted and categorized.
Time frame: From primary tympanoplasty to time of enrolment, up to 13 years
Number and Type of Medications and Therapies
Medications are obtained from medical records, counted and categorized. Therapies from medical records are listed.
Time frame: From primary tympanoplasty to time of enrolment, up to 13 years
Hearing Performance Assessed Via an Audiogram
PTA4 (0.5, 1, 2 and 4 kHz) for both air and bone conduction, under unaided and when applicable aided conditions. Data obtained from participant medical records.
Time frame: Up to 12 months prior to primary tympanoplasty
Hearing Performance Assessed Via an Audiogram
PTA4 (0.5, 1, 2 and 4 kHz) for both air and bone conduction, under unaided and when applicable aided conditions. Data obtained from participant medical records.
Time frame: Within 12 months after primary tympanoplasty
Hearing Performance Assessed Via an Audiogram
PTA4 (0.5, 1, 2 and 4 kHz) for both air and bone conduction, under unaided and when applicable aided conditions. Data obtained from participant medical records.
Time frame: Up to 6 years prior to study enrollment
Health Care Costs
Direct medical costs were calculated by applying the reported Diagnosis Related Group (DRG) codes for Chronic Otitis Media related health care utilization were obtained to the unit cost in each participating country for each participant. Note: No outcome measures are reported as there was insufficient data collection
Time frame: From primary tympanoplasty to time of enrolment.
Socio-economic Status and Health Care Data Via the Client Service Receipt Inventory (CSRI) Survey
Demographic data, medical history, hearing rehabilitation, health care utilisation related to ear infection and hearing difficulties and employment information data are collected.
Time frame: At enrolment
Self-reported Health Status and Health Related Quality of Life Via the Health Utilities Index Mark III (HUI3) Questionnaire.
HUI provides descriptive evidence on multiple dimensions of health status, a score for each dimension of health and an overall Health Related Quality of life score. The HUI3 classification system is comprised of 8 attributes: Vision, Hearing, Speech, Ambulation, Dexterity, Emotion, Cognition and Pain - each with 5 or 6 levels of ability/disability The scoring systems provide utility (preference) scores on a generic scale where 0.00 indicates death and 1.00 indicates perfect health.
Time frame: At enrolment
Self-reported Health Related Quality of Life of Participants With COM Via the Chronic Otitis Media Outcome Test-15 (COMOT-15) Questionnaire.
COMOT-15 measures Health Related Quality of life of participants with COM. It consists of three subscales: ear symptoms, hearing function, and mental health forming the overall score. In addition, two questions related to COM are asked: one on the general evaluation of quality of life and one on the frequency of doctor visits in the last six months. The total score and the sub-scores are transformed to a 0-100 scale by dividing the sum of the raw scores of the items by the sum of spans of the items, then multiplying by 100. A higher score indicates a worse health-related quality of life.
Time frame: At enrolment
Self-reported Auditory Disability Via the Speech, Spatial and Qualities of Hearing Scale (SSQ-12) Questionnaire
SSQ-12 measures speech, spatial and hearing experiences. The total(overall) score summarizes these parameters. A scale from 0 to 10 is used. A mark 0 means "be quite unable to do or experience what is described" and a mark 10 means "be perfectly able to do or experience what is described in the question".
Time frame: At enrolment
Chronic Otitis Media Outcome Test -15 (COMOT-15) Questionnaire in German, French and Spanish
Mean score of Chronic Otitis Media Outcome Test -15 (COMOT-15) in German, French and Spanish (0-100 scale). This questionnaire consists of 15 questions that query 3 subscales: ear symptoms, hearing function, and mental health. Additionally, it includes a question about quality of life and specialist doctor visit frequency. The total score is summed, transformed and presented on a 0 - 100 scale where 0 is a good outcome and 100 is the worst possible outcome.
Time frame: At enrollment
| Milestone | Observational Cohort |
|---|---|
| Started | 69 |
| Completed | 69 |
| Not completed | 0 |
Contacts are obtained from medical records, counted and categorized.
| Participants | Observational Cohort |
|---|---|
| Contact for 1 surgical procedure | 45 |
| Contact for 2 surgical procedures | 14 |
| Contact for 3 surgical procedures | 5 |
| Contact for 4 surgical procedures | 3 |
| Contact for more than four surgical procedures | 2 |
| Contact for 2 audiograms | 45 |
| Contact for 3 audiograms | 5 |
| Contact for 4 audiograms | 3 |
| Contact for more than four audiograms | 16 |
| 1 other healthcare contacts | 5 |
| 2 other healthcare contacts | 1 |
| 3 other healthcare contacts | 4 |
| 4 other healthcare contacts | 7 |
| More than 4 other healthcare contacts | 36 |
Medical examinations, surgical procedures and hearing rehabilitation are obtained from medical records, counted and categorized.
| Participants | Observational Cohort |
|---|---|
| CT scan of the temporal bone and/or sinuses | 12 |
| MRI of the temporal bone or the brain | 23 |
| another medical examination | 14 |
| primary tympanoplasty | 65 |
| revision surgeries | 25 |
| planned staged or second look surgeries | 18 |
Medications are obtained from medical records, counted and categorized. Therapies from medical records are listed.
| Participants | Observational Cohort |
|---|---|
| Antiinfective | 20 |
| Analgesics and anesthetics | 1 |
| Anilides | 14 |
| Antivertigo preparations | 3 |
| Benzodiazepine derivatives | 1 |
| Combinations of penicillins, incl. beta-lactamase inhibitors | 4 |
| Corticosteroids | 5 |
| Corticosteroids and antiinfectives in combination | 12 |
| Fluoroquinolones | 3 |
| Glucocorticoids | 5 |
| Macrolides | 1 |
| Other otologicals | 2 |
| Other cicatrizants | 1 |
| Other opioids | 6 |
| Penicillins with extended spectrum | 2 |
| Pyrazolones | 2 |
PTA4 (0.5, 1, 2 and 4 kHz) for both air and bone conduction, under unaided and when applicable aided conditions. Data obtained from participant medical records.
| db HL (decibel hearing loss) | Observational Cohort |
|---|---|
| Air Conduction | 53.2 ± 19.64 |
| Bone Conduction | 23.8 ± 14.76 |
PTA4 (0.5, 1, 2 and 4 kHz) for both air and bone conduction, under unaided and when applicable aided conditions. Data obtained from participant medical records.
| db HL (decibel hearing loss) | Observational Cohort |
|---|---|
| Air Conduction | 58.7 ± 14.9 |
| Bone conduction | 25.3 ± 14.85 |
PTA4 (0.5, 1, 2 and 4 kHz) for both air and bone conduction, under unaided and when applicable aided conditions. Data obtained from participant medical records.
| db HL (decibel hearing loss) | Observational Cohort |
|---|---|
| Air conduction | 56.7 ± 21.16 |
| Bone conduction | 25.2 ± 13.89 |
Direct medical costs were calculated by applying the reported Diagnosis Related Group (DRG) codes for Chronic Otitis Media related health care utilization were obtained to the unit cost in each participating country for each participant. Note: No outcome measures are reported as there was insufficient data collection
No measurements were reported for this outcome.
Demographic data, medical history, hearing rehabilitation, health care utilisation related to ear infection and hearing difficulties and employment information data are collected.
| Participants | Observational Cohort |
|---|---|
| married/living as married | 41 |
| single | 14 |
| widowed | 7 |
| divorced/separated | 6 |
| living with spouse/partner and children | 24 |
| living with spouse/partner without children | 19 |
| living alone | 13 |
| living with their parents | 6 |
| lived in other conditions | 6 |
| place of residence was an owner occupied flat/house | 44 |
| place of residence was a privately rented flat/house | 15 |
| place of residence was a flat/house rented from a local authority or housing association | 4 |
| other places of residence | 5 |
| highest level of education was university or higher | 20 |
| highest level of education was high school | 19 |
| highest level of education was vocational training | 17 |
| highest level of education was primary school | 12 |
| high blood pressure | 12 |
| autoimmune disease | 4 |
| cancer | 1 |
| heart disease | 5 |
| diabetes | 4 |
| chronic lung disease | 4 |
| chronic kidney disease | 2 |
| mood disorders | 8 |
| substance dependency | 1 |
| other chronic disease | 13 |
| never smoked | 39 |
| current smokers | 16 |
| previous smokers | 13 |
| full-time employment | 31 |
| retired | 20 |
| part-time employment | 5 |
| retired (because of ill health), unemployed, student or housewife/husband | 2 |
| self-employed | 1 |
| currently use a hearing aid or hearing device | 31 |
| bone conduction implant | 7 |
| visited a general practitioner | 21 |
| attended a day hospital or accident and emergency | 2 |
| visited an ENT | 31 |
| Visited audiologist | 14 |
HUI provides descriptive evidence on multiple dimensions of health status, a score for each dimension of health and an overall Health Related Quality of life score. The HUI3 classification system is comprised of 8 attributes: Vision, Hearing, Speech, Ambulation, Dexterity, Emotion, Cognition and Pain - each with 5 or 6 levels of ability/disability The scoring systems provide utility (preference) scores on a generic scale where 0.00 indicates death and 1.00 indicates perfect health.
| score on a scale | Observational Cohort |
|---|---|
| Overall | 0.7 ± 0.28 |
| Vision | 0.9 ± 0.17 |
| Hearing | 0.8 ± 0.29 |
| Speech | 0.9 ± 0.15 |
| Dexterity | 1 ± 0.11 |
| Emotion | 0.9 ± 0.16 |
| Cognition | 0.9 ± 0.14 |
| Pain | 0.9 ± 0.19 |
COMOT-15 measures Health Related Quality of life of participants with COM. It consists of three subscales: ear symptoms, hearing function, and mental health forming the overall score. In addition, two questions related to COM are asked: one on the general evaluation of quality of life and one on the frequency of doctor visits in the last six months. The total score and the sub-scores are transformed to a 0-100 scale by dividing the sum of the raw scores of the items by the sum of spans of the items, then multiplying by 100. A higher score indicates a worse health-related quality of life.
| units on a scale | Observational Cohort |
|---|---|
| Overall | 43 ± 18.25 |
| Ear symptoms | 29.4 ± 20.28 |
| Hearing function | 65 ± 22.84 |
| Mental Health | 46.5 ± 27.31 |
SSQ-12 measures speech, spatial and hearing experiences. The total(overall) score summarizes these parameters. A scale from 0 to 10 is used. A mark 0 means "be quite unable to do or experience what is described" and a mark 10 means "be perfectly able to do or experience what is described in the question".
| score on a scale | Observational Cohort |
|---|---|
| Self-reported Auditory Disability Via the Speech, Spatial and Qualities of Hearing Scale (SSQ-12) Questionnaire | 5.5 ± 2.18 |
Mean score of Chronic Otitis Media Outcome Test -15 (COMOT-15) in German, French and Spanish (0-100 scale). This questionnaire consists of 15 questions that query 3 subscales: ear symptoms, hearing function, and mental health. Additionally, it includes a question about quality of life and specialist doctor visit frequency. The total score is summed, transformed and presented on a 0 - 100 scale where 0 is a good outcome and 100 is the worst possible outcome.
| score on a scale (0-100) | Observational Cohort |
|---|---|
| German | 36.8 ± 14.76 |
| French | 46.3 ± 22.73 |
| Spanish | 45 ± 17.12 |
Collected over Not applicable. Survey administered at a single timepoint and retrospective chart review design.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Observational Cohort | — | — | — |
| Age, Continuous(years) | Observational Cohort |
|---|---|
| Mean | 50.8 ± 18.08 |
| Sex: Female, Male(Participants) | Observational Cohort |
|---|---|
| Female | 37 |
| Male | 32 |
| Race and Ethnicity Not Collected(Participants) | Observational Cohort |
|---|
| Diabetes(participants) | Observational Cohort |
|---|---|
| No | 65 |
| Yes | 4 |
| Turner Syndrome(participants) | Observational Cohort |
|---|---|
| No | 69 |
| Yes | 0 |
| Cleft Palate(participants) | Observational Cohort |
|---|---|
| No | 69 |
| Yes | 0 |
| Down Syndrome(participants) | Observational Cohort |
|---|---|
| No | 69 |
| Yes | 0 |
| Cholesteatoma(participants) | Observational Cohort |
|---|---|
| No | 33 |
| Yes | 36 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — Cochlear do not have an approved platform for public sharing of IPD collected in this study. Data may be provided to individual researchers on request.
Ran from Feb 2022 to primary completion in Oct 2023, 20 months.
Results were first posted in Mar 2025, 1 year 4 months after primary completion.
Of 22 observational studies under Otitis Media, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 67. This study's 20 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.